TP53 and cancer: Gain of function p53 mutants such as R175H, which is associated with the core cancers in LFS patients, interact with the mevalonate pathway in a positive feedback loop which confers stabilisation of the mutant p53 proteins, which then up-regulates lipid metabolism [84,85].